Literature DB >> 12224404

Distribution of 5HT2A receptors in the human brain: comparison of data in vivo and post mortem.

F Forutan1, S Estalji, M Beu, S Nikolaus, K Hamacher, H H Coenen, H Vosberg, H W Müller-Gärtner, R Larisch.   

Abstract

AIM: The study presented here firstly compares the distribution of the binding potential of the serotonin-5HT2A receptor as measured in vivo with data of receptor density taken from literature. Secondly, the sensitivity of the method to detect gradual differences in receptor densities is evaluated.
METHODS: Positron emission tomography (PET) studies were carried out in 6 healthy volunteers using the selective serotonin-5HT2A ligand 18F-altanserin. The binding potential was quantified in 12 regions using Logan's graphical method and the equilibrium method. These data were compared to the distribution of receptor density as taken from literature.
RESULTS: The binding data in vivo correlated to autoradiography data (post mortem) with r = 0.83 (Pearson regression coefficient; p < 0.0001). A difference in the receptor density between two regions could be detected with p < 0.05 when it amounted at least to 18%.
CONCLUSION: This study demonstrates a good agreement between in vivo data obtained with 18F-altanserin and PET in healthy volunteers and the true autoradiographically determined distribution of 5HT2A receptors in human brains. The in vivo method seems to be sensitive enough to detect changes in receptor density of more than 18%.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12224404

Source DB:  PubMed          Journal:  Nuklearmedizin        ISSN: 0029-5566            Impact factor:   1.379


  6 in total

Review 1.  PET tracers for serotonin receptors and their applications.

Authors:  J S Dileep Kumar; J John Mann
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2014

2.  Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers.

Authors:  Boris B Quednow; Michael Kometer; Mark A Geyer; Franz X Vollenweider
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

3.  Genetic variation of serotonin receptor function affects prepulse inhibition of the startle.

Authors:  David Bräuer; Alexander Strobel; Tilman Hensch; Kersten Diers; Klaus-Peter Lesch; Burkhard Brocke
Journal:  J Neural Transm (Vienna)       Date:  2009-04-08       Impact factor: 3.575

4.  Suitability of [18F]altanserin and PET to determine 5-HT2A receptor availability in the rat brain: in vivo and in vitro validation of invasive and non-invasive kinetic models.

Authors:  Tina Kroll; David Elmenhorst; Andreas Matusch; Franziska Wedekind; Angela Weisshaupt; Simone Beer; Andreas Bauer
Journal:  Mol Imaging Biol       Date:  2013-03-01       Impact factor: 3.488

5.  Does Serotonin Play a Role in Epilepsy?

Authors:  William H. Theodore
Journal:  Epilepsy Curr       Date:  2003-09       Impact factor: 7.500

6.  Genes within the serotonergic system are differentially expressed in human brain.

Authors:  Karen Sugden; Ales Tichopad; Nadeem Khan; Ian W Craig; Ursula M D'Souza
Journal:  BMC Neurosci       Date:  2009-05-15       Impact factor: 3.288

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.